UBS ASSET MANAGEMENT AMERICAS LLC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 167 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS LLC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$13,890,068,000
+55.2%
149,452
-0.6%
0.01%
+25.0%
Q3 2021$8,950,961,000
-15.0%
150,310
-2.7%
0.00%
-20.0%
Q2 2021$10,531,034,000
-2.7%
154,414
-1.1%
0.01%0.0%
Q1 2021$10,828,655,000
-64.5%
156,055
-60.7%
0.01%
-64.3%
Q4 2020$30,514,724,000
+148.3%
397,172
+141.7%
0.01%
+100.0%
Q3 2020$12,290,615,000
+23.8%
164,335
+4.2%
0.01%
+16.7%
Q2 2020$9,929,420,000
+326.5%
157,735
+184.5%
0.01%
+200.0%
Q1 2020$2,328,354,000
-7.1%
55,437
+0.4%
0.00%0.0%
Q4 2019$2,506,820,000
+2.2%
55,192
+3.0%
0.00%0.0%
Q3 2019$2,453,134,000
+3.2%
53,597
+32.3%
0.00%0.0%
Q2 2019$2,376,098,000
+42.1%
40,527
+8.6%
0.00%
+100.0%
Q1 2019$1,672,427,000
+20.1%
37,306
+4.3%
0.00%0.0%
Q4 2018$1,392,969,000
-5.5%
35,763
+11.7%
0.00%0.0%
Q3 2018$1,473,607,000
+5.6%
32,0210.0%0.00%0.0%
Q2 2018$1,396,115,000
+75.9%
32,021
+59.3%
0.00%0.0%
Q1 2018$793,793,000
+62.4%
20,096
+39.7%
0.00%
Q4 2017$488,693,00014,3860.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Prosight Management, LP 252,500$11,320,0004.95%
Rubric Capital Management LP 857,103$38,424,0003.59%
PFM Health Sciences, LP 3,255,230$145,932,0003.22%
Partner Investment Management, L.P. 40,605$1,820,0002.10%
DAFNA Capital Management LLC 93,942$4,211,0001.82%
Atika Capital Management LLC 195,000$8,742,0001.78%
Perceptive Advisors 1,400,171$62,770,0001.77%
EMORY UNIVERSITY 47,779$2,142,0001.51%
Rhenman & Partners Asset Management AB 234,558$10,515,0001.23%
Eversept Partners, LP 75,721$3,394,5720.99%
View complete list of ARENA PHARMACEUTICALS INC shareholders